What laboratory tests should be ordered before referring a patient to nephrology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests to Order Before Nephrology Referral

Essential Basic Laboratory Panel

Before referring any patient to nephrology, order a comprehensive metabolic panel that includes serum creatinine with calculated eGFR, blood urea nitrogen (BUN), electrolytes (sodium, potassium, chloride, bicarbonate), calcium, and liver function tests. 1, 2

Core Kidney Function Tests

  • Serum creatinine and eGFR are mandatory to stage CKD and determine urgency of referral 3, 2
  • Urinalysis with microscopy to detect hematuria, pyuria, casts, and crystals 1, 2
  • Urine albumin-to-creatinine ratio (UACR) or protein-to-creatinine ratio (PCR) from a spot urine sample to quantify proteinuria 3, 2
    • Two of three specimens collected within 3-6 months should be abnormal to confirm persistent albuminuria 3

Complete Blood Count and Additional Tests

  • CBC to assess for anemia of chronic kidney disease 1, 4
  • Serum calcium, phosphorus, and alkaline phosphatase to evaluate for CKD mineral and bone disorder 1
  • Lactate dehydrogenase (LDH) may be included at physician discretion 1, 4

Electrolyte Assessment

  • Serum potassium is critical as persistent hyperkalemia is itself an indication for nephrology referral 2
  • Serum bicarbonate to assess for metabolic acidosis 1

Timing and Interpretation Considerations

Establish Baseline and Trend

  • Obtain at least two eGFR measurements 3-6 months apart to calculate rate of decline and distinguish acute from chronic kidney disease 2
  • A rapid decline >5 mL/min/1.73 m² per year or abrupt sustained decrease >20% warrants urgent referral 2

Proteinuria Quantification

  • Persistent proteinuria >1 g/day (ACR ≥60 mg/mmol or PCR ≥100 mg/mmol) is an absolute indication for nephrology referral regardless of eGFR 2
  • Normal to mildly increased albuminuria (<30 mg/g, category A1) does not require specialist input if eGFR is stable 3, 2

Special Populations

Diabetic Patients

  • Hemoglobin A1c to assess glycemic control 3
  • Lipid panel as cardiovascular risk is the primary concern in early CKD 3
  • Absence of diabetic retinopathy with significant proteinuria suggests non-diabetic kidney disease and warrants referral 2

Patients with Hematuria

  • Urine microscopy showing >20 RBCs per high-power field or red blood cell casts requires nephrology evaluation 2
  • Consider urine cytology if central renal mass suggests urothelial carcinoma 4

Common Pitfalls to Avoid

  • Do not refer based on a single elevated creatinine without confirming it is sustained and excluding reversible causes like volume depletion, medication effects, or obstruction 2
  • Do not order a bone scan or brain imaging unless the patient has specific symptoms (bone pain, elevated alkaline phosphatase, neurological signs) 1
  • Do not delay obtaining urine albumin quantification - dipstick protein alone is insufficient for staging and risk stratification 3, 2
  • Do not fail to adjust medication dosages based on eGFR before referral, as this is a primary care responsibility 3, 2

When These Labs Indicate Referral

Refer immediately if labs show: 2, 5

  • eGFR <30 mL/min/1.73 m²
  • Proteinuria >1 g/day
  • Rapid eGFR decline >5 mL/min/1.73 m² per year
  • Persistent hyperkalemia despite treatment
  • Urinary RBC casts or >20 RBCs/HPF without clear explanation

Consider referral for diabetic patients with: 3, 2

  • eGFR <60 mL/min/1.73 m² plus difficult-to-control hypertension or electrolyte abnormalities
  • Continuously increasing albuminuria despite optimal treatment
  • Absence of retinopathy with significant proteinuria (suggests non-diabetic kidney disease)

References

Guideline

Referral Guidelines for Nephrology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

kidney cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

Guideline

Nephrology Referral Thresholds Based on eGFR

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

When should a patient be referred to a nephrologist (kidney specialist)?
In a patient with urine dipstick positive for bilirubin (2+) and protein (1+) presenting with flank pain, what is the appropriate management?
How should a patient with chronic kidney disease stage 3 be evaluated and managed for new gross hematuria (urinalysis >25 red blood cells per high-power field) after laparoscopic cholecystectomy with intraoperative cholangiogram?
What is the interpretation of a urinalysis (UA) with dark yellow color, cloudy appearance, negative glucose, trace bilirubin, negative ketones, specific gravity of 1.025, large blood presence, abnormal pH of 5.5, protein level of 100 mg/dL, urobilinogen level of 0.2 mg/dL, negative nitrite, and 1+ leukocytes?
Is a first morning void sample necessary for urinalysis and urine culture in a patient with variable urine pH levels and positive leukocytes (white blood cells)?
What causes gastric herniation into the esophagus?
What are the causes of syncope that occur during or immediately after a Valsalva maneuver?
Can I administer 4 g of magnesium sulfate intravenously over one hour in an adult with normal renal function and no cardiac conduction abnormalities?
How should fast breathing be evaluated and managed in a child aged 2 months to 5 years?
How should a simple furuncle be managed compared to a carbuncle, including wound care, incision and drainage, and appropriate oral or intravenous antibiotic therapy?
In a patient with coronary artery disease who has received a drug‑eluting stent, how long should ticagrelor (Brilinta) be continued?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.